Jim Newcombe

CEO & Managing Director (from Nov 2025), Sonic Healthcare

CEOHealthcareNSW

Dr Jim Newcombe is the Managing Director and Chief Executive Officer of Sonic Healthcare Limited, the global laboratory medicine and pathology group, effective 20 November 2025, succeeding long-serving CEO Dr Colin Goldschmidt. A pathologist specialising in clinical microbiology and an infectious diseases physician, he was previously CEO of Douglass Hanly Moir Pathology, Sonic's founding practice in Sydney.

Fast facts

Role	CEO & Managing Director (from Nov 2025)
Company	Sonic Healthcare ASX:SHL
Sector	Healthcare / Pathology
Headquarters	NSW
In role since	2025
Education	Trained in medicine in Australia and qualified as a pathologist and infectious diseases physician; completed the United States Medical Licensing Examination and held medical appointments in the USA.

Background

Appointed Managing Director and CEO in November 2025 succeeding long-serving Dr Colin Goldschmidt; internal executive who took over the global pathology and diagnostic imaging group.

Career timeline

2017Joined Sonic Healthcare
2025Appointed Managing Director and CEO of Sonic Healthcare, effective 20 November

Notable

A pathologist specialising in clinical microbiology and an infectious diseases physician
As CEO of Douglass Hanly Moir Pathology he led a significant uplift in earnings and margins through operations, marketing and people initiatives
Succeeded Dr Colin Goldschmidt, who had led Sonic Healthcare for decades

Frequently asked questions

When did Jim Newcombe become CEO of Sonic Healthcare?

He became Managing Director and CEO of Sonic Healthcare effective 20 November 2025.

What was Jim Newcombe's role before becoming CEO?

He was CEO of Douglass Hanly Moir Pathology, Sonic Healthcare's founding practice in Sydney.

Public profiles

https://www.sonichealthcare.com/about-sonic/global-leadership-group/

Sources

Last verified 2026-07-13. Professionally-public, sourced information only.